Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Search Results (671)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific Autoantibodies.Academic Article Why?
Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders.Academic Article Why?
Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers.Academic Article Why?
Antiislet autoantibodies usually develop sequentially rather than simultaneously.Academic Article Why?
Antinuclear autoantibodies in uveitis.Academic Article Why?
Collagen autoantibodies in patients with vasculitis and systemic lupus erythematosus.Academic Article Why?
Editorial: Autoantibodies in Kidney Diseases.Academic Article Why?
Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes.Academic Article Why?
Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma.Academic Article Why?
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.Academic Article Why?
Autoantibodies to hybrid insulin peptides in type 1 diabetesGrant Why?
RA-Related Autoantibodies in Healthy FDR of RA PatientsGrant Why?
Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.Academic Article Why?
Electrochemiluminescence Assays for Human Islet Autoantibodies.Academic Article Why?
Endocrine autoantibodies.Academic Article Why?
Per Page    Page  of 45last Nextnext
Prev
Search Criteria
  • Autoantibodies
Filter by Type

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)